Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Thomas P Lodise & Sanjay Sethi. (2021) Response to the Letter to the Editor Regarding “Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies” [Response to Letter]. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1227-1229.
Read now
Read now
Ji-Ho Lee, You Hyun Park, Dae Ryong Kang, Seok Jeong Lee, Myoung Kyu Lee, Sang-Ha Kim, Suk Joong Yong & Won-Yeon Lee. (2020) Risk of Pneumonia Associated with Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease: A Korean Population-Based Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3397-3406.
Read now
Read now
Thomas P Lodise, Jingyi Li, Hitesh N Gandhi, Gerald O’Brien & Sanjay Sethi. (2020) Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2889-2900.
Read now
Read now
Paolo Solidoro, Filippo Patrucco & Diego Bagnasco. (2019) Comparing a fixed combination of budesonide/formoterol with other inhaled corticosteroid plus long-acting beta-agonist combinations in patients with chronic obstructive pulmonary disease: a review. Expert Review of Respiratory Medicine 13:11, pages 1087-1094.
Read now
Read now
Kylie BR Belchamber, Catherine MR Thomas, Amy E Dunne, Peter J Barnes & Louise E Donnelly. (2018) Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2883-2897.
Read now
Read now
Chih-Cheng Lai, Ya-Hui Wang, Cheng-Yi Wang, Hao-Chien Wang, Chong-Jen Yu & Likwang Chen. (2018) Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 867-874.
Read now
Read now
Donald P Tashkin & Michael E Wechsler. (2018) Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 335-349.
Read now
Read now
Yueh Lan Huang, Chih-Cheng Lai, Ya-Hui Wang, Cheng-Yi Wang, Jen-Yu Wang, Hao-Chien Wang, Chong-Jen Yu & Likwang Chen. (2017) Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2987-2996.
Read now
Read now
Hsi-Hsing Yang, Chih-Cheng Lai, Ya-Hui Wang, Wei-Chih Yang, Cheng-Yi Wang, Hao-Chien Wang, Likwang Chen & Chong-Jen Yu. (2017) Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2477-2485.
Read now
Read now
Klaus F. Rabe. (2017) GFF MDI for the improvement of lung function in COPD – A look at the PINNACLE-1 and PINNACLE-2 data and beyond. Expert Review of Clinical Pharmacology 10:7, pages 685-698.
Read now
Read now
Articles from other publishers (18)
Takashi Sato & Takeshi Shimosato. 2023. A Compendium of Chronic Obstructive Pulmonary Disease. A Compendium of Chronic Obstructive Pulmonary Disease.
Bansree Patel & Ronny Priefer. (2022) Impact of chronic obstructive pulmonary disease, lung infection, and/or inhaled corticosteroids use on potential risk of lung cancer. Life Sciences 294, pages 120374.
Crossref
Crossref
Chin-Chung Shu, Yu-Feng Wei, Kuang-Hung Chen, Shulin Chuang, Ya-Hui Wang, Cheng-Yi Wang & Hao-Chien Wang. (2022) Inhaled Corticosteroids Increase Risk of Nontuberculous Mycobacterial Lung Disease: A Nested Case-Control Study and Meta-analysis. The Journal of Infectious Diseases 225:4, pages 627-636.
Crossref
Crossref
Steven R. White & Yvonne J. Huang. 2022. The Microbiome in Respiratory Disease. The Microbiome in Respiratory Disease
85
146
.
Marc Miravitlles, Ariadna Auladell-Rispau, Mònica Monteagudo, Juan Carlos Vázquez-Niebla, Jibril Mohammed, Alexa Nuñez & Gerard Urrútia. (2021) Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD. European Respiratory Review 30:160, pages 210075.
Crossref
Crossref
Cheng-Yi Wang & Chih-Cheng Lai. (2021) The association between inhaled corticosteroid and osteoporosis and fracture. European Respiratory Journal 57:6, pages 2100216.
Crossref
Crossref
Tetyana Kendzerska, Shawn D. Aaron, Teresa To, Chris Licskai, Matthew B. Stanbrook, Mary-Ellen Hogan, Wan C. Tan, Jean Bourbeau & Andrea S. Gershon. (2021) Effect of type and dosage of newly prescribed inhaled corticosteroids on obstructive lung disease and pneumonia hospitalisations in older individuals with asthma, COPD or both: a retrospective study of health administrative data. European Respiratory Journal 57:1, pages 2002585.
Crossref
Crossref
Tsan-Ming Huang, Kuan-Chih Kuo, Ya-Hui Wang, Cheng-Yi Wang, Chih-Cheng Lai, Hao-Chien Wang, Likwang Chen, Chong-Jen Yu, Chong-Jen Yu, Hao-Chien Wang, Diahn-Warng Perng, Shih-Lung Cheng, Jeng-Yuan Hsu, Wu-Huei Hsu, Jeng-Yuan Hsu, Wu-Huei Hsu, Ying-Huang Tsai, Tzuen-Ren Hsiue, Meng-Chih Lin, Hen-I Lin, Cheng-Yi Wang, Yeun-Chung Chang, Ueng-Cheng Yang, Cing-Syong Lin, Likwang Chen, Yu-Feng Wei, Inn-Wen Chong & Chung-Yu Chen. (2020) Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids. BMC Infectious Diseases 20:1.
Crossref
Crossref
Donald P. Tashkin. (2020) Further Evidence of Varying Risks and Benefits of Different Inhaled Corticosteroid/Long-acting Beta-agonist Combinations in COPD. Chest 157:5, pages 1067-1069.
Crossref
Crossref
Ting-Yu Chang, Jung-Yien Chien, Chung-Hsuen Wu, Yaa-Hui Dong & Fang-Ju Lin. (2020) Comparative Safety and Effectiveness of Inhaled Corticosteroid and Long-Acting β2-Agonist Combinations in Patients With COPD. Chest 157:5, pages 1117-1129.
Crossref
Crossref
Mingjin Yang, Yuejun Du, Hong Chen, Depeng Jiang & Zhibo Xu. (2019) Inhaled corticosteroids and risk of pneumonia in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials. International Immunopharmacology 77, pages 105950.
Crossref
Crossref
Cheng-Yi Wang, You Shuei Lin, Ya-Hui Wang, Chih-Cheng Lai, Hao-Chien Wang, Likwang Chen & Chong-Jen Yu. (2019) Risk of sepsis among patients with COPD treated with fixed combinations of inhaled corticosteroids and long-acting Beta2 agonists. Aging 11:17, pages 6863-6871.
Crossref
Crossref
Chih-Cheng LaiYa-Hui WangCheng-Yi WangHao-Chien WangChong-Jen YuLikwang Chen. (2019) Risk of Sepsis and Mortality Among Patients With Chronic Obstructive Pulmonary Disease Treated With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers. Critical Care Medicine 47:1, pages e14-e20.
Crossref
Crossref
Erminia Ridolo, Cristoforo Incorvaia, Irene Martignago, Laura Pessina, Fulvio Lauretani, Luciano Loperfido, Gian Galeazzo Riario-Sforza, Annalisa Broglia, Bruna L. Gritti & Lorenzo Panella. (2018) Low incidence of pneumonia in COPD patients treated with inhaled corticosteroids undergoing pulmonary rehabilitation. Clinical and Molecular Allergy 16:1.
Crossref
Crossref
Cheng-Hsin Chen, Chih-Cheng Lai, Ya-Hui Wang, Cheng-Yi Wang, Hao-Chien Wang, Chong-Jen Yu & Likwang Chen. (2018) The Impact of Sepsis on the Outcomes of COPD Patients: A Population-Based Cohort Study. Journal of Clinical Medicine 7:11, pages 393.
Crossref
Crossref
M. van den Berge, M.R. Jonker, A. Miller-Larsson, D.S. Postma & I.H. Heijink. (2018) Effects of fluticasone propionate and budesonide on the expression of immune defense genes in bronchial epithelial cells. Pulmonary Pharmacology & Therapeutics 50, pages 47-56.
Crossref
Crossref
Nitin Kapur, Helen L Petsky, Scott Bell, John Kolbe & Anne B Chang. (2018) Inhaled corticosteroids for bronchiectasis. Cochrane Database of Systematic Reviews 2018:5.
Crossref
Crossref
Joy Creaser-Thomas, Vignesh Rajasundaram & Gwyneth A Davies. 2017. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
161
171
.